CD8A and neoplasm: We recently found that lymphatic PD-L1 can also impair tumor-specific T cell responses in melanoma-draining LNs (47), and that in the B16F10 melanoma model, EVs can transfer a model antigen from primary tumor cells to draining LN LECs, resulting in impaired CD8+ T cell responses (36).